- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| CANNABIS POLAND Aktie jetzt für 0€ handeln |
0 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| MPH HEALTH CARE | 28,100 | -0,71 % | Original-Research: MPH Health Care AG (von First Berlin Equity Research GmbH): Kaufen | Original-Research: MPH Health Care AG - from First Berlin Equity Research GmbH
21.09.2026 / 13:15 CET/CEST
Dissemination of a Research, transmitted by EQS News - a service of EQS Group.
The issuer... ► Artikel lesen | |
| COMPASS PATHWAYS | 10,300 | -0,96 % | Renditeschock trifft Biotech: Wie Compass Pathways und Definium Therapeutics um Kapital ringen - und wo Emyria steht | ||
| HIGH TIDE | 2,340 | -1,27 % | High Tide erwirbt etablierten Cannabis-Laden in Chestermere, Alberta | CALGARY, AB / 9. Oktober 2026 / IRW-Press / High Tide Inc. ("High Tide" oder das "Unternehmen") (Nasdaq: HITI) (TSXV: HITI) (FWB: 2LYA), das erfolgreiche, auf
den Einzelhandel fokussierte Unternehmen... ► Artikel lesen | |
| SHANGHAI FOSUN PHARMACEUTICAL | 1,830 | -1,72 % | Shanghai Fosun Pharmaceutical (Group) Co., Ltd.: Fosun Pharma Announces H-Share Repurchase Plan of Up to HK$ 1 Billion | SHANGHAI, Sept 7, 2026 - (ACN Newswire) - Shanghai Fosun Pharmaceutical (Group) Co., Ltd. ('Fosun Pharma', stock code: 600196.SH; 02196.HK) today announced an H share repurchase plan, under which the... ► Artikel lesen | |
| SAVARA | 3,936 | -2,41 % | Savara Inc.: Savara Announces Encore Presentations of Results from the Phase 3 Clinical Trial of Molgramostim Inhalation Solution (Molgramostim) in Autoimmune Pulmonary Alveolar Proteinosis (APAP) at the European Respiratory Society (ERS) Congress 2026 | -- Company to Host Industry Evening Mini-Symposium on aPAP with Renowned Key Opinion Leaders --Savara Inc. (Nasdaq: SVRA), a clinical stage biopharmaceutical company focused on rare respiratory diseases... ► Artikel lesen | |
| PROMINO NUTRITIONAL SCIENCES | 0,019 | 0,00 % | Promino Nutritional Sciences, Inc.: Promino Secures Social Commerce Distribution Agreement for US$5 Million Minimum Product Purchases | Social Commerce Brands to purchase a minimum US$1 million of Promino products in Q4 2026 and each quarter of 2027 while funding and operating designated direct-to-consumer and social commerce channelsBurlington... ► Artikel lesen | |
| EVOLUS | 6,500 | -1,54 % | Biotech Stocks At 52-Week Highs - RenovoRx +15%, Evolus, Crinetics Pharmaceuticals, Apogee Therapeutics | CAMBRIDGE (MASSACHUSETTS) (dpa-AFX) - The following biotech stocks reached a 52-week high on August 31, 2026, driven by achieving new regulatory milestones or an upcoming acquisition.RenovoRx... ► Artikel lesen | |
| ATYR PHARMA | 0,175 | +14,01 % | aTyr Pharma partners with Einstein on cancer research | ||
| MINDWALK | 1,060 | -0,93 % | MindWalk Holdings Corp. Announces Leadership Update | Commercial Priorities Unchanged; LensAI Remains in Contracted, Recurring Deployments with Life Sciences Customers
MindWalk Holdings Corp. ("MindWalk") (NASDAQ: HYFT), a Bio-Native AI company, today... ► Artikel lesen | |
| CIPHER PHARMACEUTICALS | 8,300 | 0,00 % | Cipher Pharmaceuticals Announces the Appointment of Rajiv De Silva to its Board of Directors | ||
| STEVANATO GROUP | 17,200 | 0,00 % | Stevanato Group S.p.A.: Stevanato Group to Report Third Quarter 2026 Financial Results on November 3, 2026 | Stevanato Group S.p.A. (NYSE: STVN), a leading global provider of drug containment, drug delivery, and diagnostic solutions to the pharmaceutical, biotechnology, and life sciences industries, announced... ► Artikel lesen | |
| NANO HOLDINGS | 0,432 | -1,82 % | Forge Nano Holdings, Inc. - 8-K, Current Report | ||
| NIPPON KAYAKU | 11,400 | +0,88 % | Dividendenbekanntmachungen (29.09.2026) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) 77 BANK LTD JP3352000008 52 JPY 0,2906 EUR ACADIAN TIMBER CORP CA0042721005 0,29 CAD 0,1799 EUR ACOM CO LTD JP3108600002 11 JPY 0... ► Artikel lesen | |
| TEVA PHARMACEUTICAL INDUSTRIES | 40,180 | -0,04 % | Teva/Sanofi: Duvakitug Maintains Meaningful Efficacy Improvements In Long-term Extension Study | PETAH TIKVA (dpa-AFX) - Teva Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical Industries (TEVA), and Sanofi announced new positive data from the RELIEVE UCCD phase 2b long-term extension... ► Artikel lesen | |
| ETON PHARMACEUTICALS | 50,13 | +0,22 % | Biotech Stocks At 52-Week Highs - Eton Pharmaceuticals +44%, DexCom, Oruka Therapeutics, Concentra Group Holdings Parent, AtaiBeckley | INDIANAPOLIS (dpa-AFX) - The following biotech stocks reached 52-week highs on August 14, 2026, following positive quarterly reports or an announced upcoming acquisition. Eton Pharmaceuticals... ► Artikel lesen |
CANNABIS POLAND SA gehört der Branche Pharma an. Der aktuelle Kurs liegt bei 0,033 Euro und damit 0,00 % im Plus.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu CANNABIS POLAND SA finden Sie auf Wallstreet Online.